The novel therapy of the medication represents a major development in the care of the condition. Unlike existing drugs, tirzepatide targets two pathways – GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) https://tirzepatidepeptide642202.mybjjblog.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-54201451